Review of Charts From Amish/Mennonite Variant PA Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03159026|
Recruitment Status : Recruiting
First Posted : May 18, 2017
Last Update Posted : May 24, 2018
|Condition or disease|
The study is designed to provide a comprehensive description of the clinical and biochemical features of propionic academia, Amish/Mennonite variant (PA-AMV). From these data, the investigators hope to identify biomarkers for assessment of clinical course and efficacy of ongoing management.
The investigators plan to identify essentially all known patients who have the Amish/Mennonite variant of Propionic academia (PA-AMV) through collaboration with clinicians who proved care to this extended community. Signed consents include permission to access life-long medical records to allow investigators to define the natural history of this biochemical variant condition. This will include a description the clinical and biochemical features and natural history of patients with propionic acidemia in the Amish/Mennonite population. In particular, there is interest in the cardiac complications of this variant, so investigators will analyze EKG, echo and cardiac MRI findings in above patients. These data will be used to Identify biomarkers for clinical assessment and ongoing management.
There has been no published data on patients with PA-AMV since 1980. Accumulated clinical experience with PA Amish/Mennonite variant patients suggests that these patients tend to have less severe clinical features compared to classic PA. Severe neonatal metabolic decompensation and ketoacidosis are not present in Amish/Mennonite patients we have followed. Describing the natural history and clinical course is essential in this group of patients to further guide their management. There is currently no evidence-based approach to care of these patients, but rather individual medical centers manage patients symptomatically and differently. A uniform, data-driven approach to patient management is needed.
|Study Type :||Observational|
|Estimated Enrollment :||150 participants|
|Official Title:||Chart Review of Patients Who Have the Amish/Mennonite Variant of Propionic Acidemia|
|Actual Study Start Date :||April 6, 2017|
|Estimated Primary Completion Date :||April 15, 2022|
|Estimated Study Completion Date :||April 15, 2022|
- Clinical and biochemical natural history of Amish/Mennonite PA variant [ Time Frame: Through study completion, an average of one year. ]Chart review to describe clinical and biochemical features of Amish/Mennonite PA variant
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03159026
|Contact: Cate Walsh Vockley, MS, LCGCfirstname.lastname@example.org|
|Contact: Jennifer Baker, MAemail@example.com|
|United States, Pennsylvania|
|Children's Hospital of Pittsburgh||Recruiting|
|Pittsburgh, Pennsylvania, United States, 15224|
|Contact: Cate Walsh Vockley, MS, LCGC 412-692-7349 Catherine.firstname.lastname@example.org|
|Contact: Ahmad Alhariri, MD email@example.com|